Reciprocal interactions between lncRNAs and MYC in colorectal cancer: partners in crime

Zhen Lei1, Zhipu Zhu1, Zhihui Yao1

  • 1Translational Research Institute, People's Hospital of Zhengzhou University, Academy of Medical Science, Henan International Joint Laboratory of Non-coding RNA and Metabolism in Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, 450003, China.

Cell Death & Disease
|July 29, 2024
PubMed

Insights

This review explores the MYC and long noncoding RNA (lncRNA) axis in colorectal cancer (CRC). It details their reciprocal regulation and roles, highlighting potential therapeutic strategies for CRC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Proto-oncogenic MYC is frequently dysregulated in colorectal cancer (CRC).
  • Long noncoding RNAs (lncRNAs) are critical regulators in cancer development.
  • A complex interplay exists between MYC and lncRNAs in various cancers, including CRC.

Purpose of the Study:

  • To review the current understanding of the MYC and lncRNA axis in CRC.
  • To elucidate the mutual regulatory mechanisms between MYC and lncRNAs.
  • To explore the therapeutic potential of targeting this axis in CRC.

Main Methods:

  • Literature review of studies investigating MYC and lncRNA interactions in CRC.
  • Analysis of the roles of lncRNAs in regulating MYC expression and activity.
  • Examination of MYC's influence on lncRNA transcription and function.

Main Results:

  • MYC and lncRNAs exhibit reciprocal regulatory interactions in CRC.
  • lncRNAs modulate MYC expression at both transcriptional and post-transcriptional levels.
  • MYC influences lncRNA transcription, affecting cell fate decisions in CRC.

Conclusions:

  • The MYC-lncRNA axis plays a significant role in CRC pathogenesis.
  • Targeting the MYC-lncRNA interaction presents a promising therapeutic avenue for CRC.
  • Further research into this axis could lead to novel CRC treatment strategies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K